Proudfoot et al.5
|
UK: London, Edinburgh, Scotland |
71 |
Patients with paraquat levels less than a line connecting concentrations of 2.0, 0.6, 0.3, 0.16 and 0.1 μg/ml at 4, 6, 10, 16 and 24 h survive. |
No |
Applicable only between 4 and 24 h. |
Hart et al.7
|
UK |
219 |
Graph plasma paraquat levels vs. time since ingestion. Generating contour map lines denoting equal probability of survival. |
No |
Applicable up to 28 h. Nomogram unable to assign risk to concentrations taken <4 h which are > 5.5 μg/ml. |
Scherrmann et al.6
|
France |
30 |
Survivors have plasma paraquat levels less than C μg/ml where C = 1/(0.471 × (h since ingestion) −1.302) |
No |
Curve is used to extend Proudfoot for use beyond 24 h. Applicable >4 h. |
Sawada et al.8
|
Japan |
30 |
SIPP = time to treatment (h) × serum PQ concentration (μg/ml) SIPP < 10 predicts survival SIPP 10–50 death from lung fibrosis, SIPP > 50 death from circulatory failure. |
No |
Applicable up to 200 h. |
Jones et al.4
|
Review of worldwide literature |
375 |
Probability of survival = exp(logit)/[1 + exp(logit)] Logit = 0.58−[2.33 × log10 (plasma paraquat μg/ml)] − [1.15 × log10 (h since ingestion)] |
No |
Applicable up to 200 h. |